Form D/A — Circle Pharma, Inc.
0001684286-25-000001 · filed Jan 10, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- Rule 506(b)
- Reported offering amount
- $117,374,782
- Reported amount sold
- $92,444,167
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Circle Pharma, Inc.
- CIK
- 1684286
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 681 GATEWAY BLVD
SOUTH SAN FRANCISCO, California 94080 - Phone
- 650-392-0350
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John Josey · DirectorSOUTH SAN FRANCISCO, California Find on LinkedIn ↗
-
David J. Earp · Executive OfficerSOUTH SAN FRANCISCO, California Find on LinkedIn ↗
-
Matthew P. Jacobson · DirectorSOUTH SAN FRANCISCO, California Find on LinkedIn ↗
-
Walter H. Moos · DirectorSOUTH SAN FRANCISCO, California Find on LinkedIn ↗
-
James Evangelista · DirectorSOUTH SAN FRANCISCO, California Find on LinkedIn ↗
-
Stephen Kelsey · DirectorSOUTH SAN FRANCISCO, California Find on LinkedIn ↗
-
Thilo Schroeder · DirectorSOUTH SAN FRANCISCO, California Find on LinkedIn ↗
-
Paul Park · Executive OfficerSOUTH SAN FRANCISCO, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗